Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOME-trial
NCT00375388Phase 3Completed
- Sponsor
- Bethesda General Hospital
- Start
- Jan 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Bethesda General Hospital. Started Jan 1998; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00375388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375388.